Sort
46,585 grants matching “heart failure”
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure
$836,075Jeffrey M Testani · Yale University · R01 · FY2019 · HL
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure
$836,075Jeffrey M Testani · Yale University · R01 · FY2021 · HL
The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study
$835,983Valerie G Press · University Of Chicago · R01 · FY2020 · HL
Chronic Kidney Disease Prognosis Consortium (CKD-PC)
$835,918Josef Coresh · New York University School Of Medicine · R01 · FY2024 · DK
Proteomic signatures to identifypathways underlying the progression toheart failure
$835,882Amil M Shah · Brigham And Women'S Hospital · R01 · FY2021 · HL
Hypertension Pharmacogenetics
$835,849University Of Florida · R01 · FY2005 · HL
Probing Phenotype-Genotype Relations After Whole Genome Sequencing in Patients with Atrial Fibrillation
$835,785Moore Benjamin Shoemaker · Vanderbilt University Medical Center · R01 · FY2023 · HL
Ion Channels and Sudden Cardiac Death
$835,574Robert S Kass · Columbia University Health Sciences · P01 · FY2007 · HL
Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice
$835,484Susana T Valente · University Of Florida · R01 · FY2025 · AI
In-Situ Lead Tester for Implantable Devices
$835,296Patrick Allan Lichter · Koronis Biomedical Technologies Corporat · R44 · FY2017 · AG
Drosophila models of human mitochondrial diseases
$835,142Norbert Perrimon · Harvard Medical School · R24 · FY2024 · OD
Multiparametric PET/MRI Assessment of Mast Cell Stabilization Effects on Inflammaging and Glucose Utilization in Infarcted Myocardium
$834,918Ivan Cokic · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Multiparametric PET/MRI Assessment of Mast Cell Stabilization Effects on Inflammaging and Glucose Utilization in Infarcted Myocardium
$834,918Ivan Cokic · Cedars-Sinai Medical Center · R01 · FY2025 · HL
Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI
$834,798Debiao Li · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy
$834,439Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · HL
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval
$834,434Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2016 · HL
Exosome Therapeutics to Dissect HFpEF Mechanisms
$834,431Jennifer E Van Eyk · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Exosome Therapeutics to Dissect HFpEF Mechanisms
$834,431Jennifer E Van Eyk · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Exosome Therapeutics to Dissect HFpEF Mechanisms
$834,431Jennifer E Van Eyk · Cedars-Sinai Medical Center · R01 · FY2021 · HL
Impact of Medically Tailored Meals on Obesity, Other Health Outcomes, and Healthcare Utilization under Medicaid Flexible Services
$834,348Dariush Mozaffarian · Tufts University Boston · R01 · FY2022 · DK
Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study
$833,910Jeffrey M Testani · Yale University · R01 · FY2019 · HL
Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy
$833,881Ivan Luptak · Boston Medical Center · R01 · FY2024 · HL
Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart Disease
$833,781David Ouyang · Cedars-Sinai Medical Center · R01 · FY2025 · HL
Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart Disease
$833,781David Ouyang · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Molecular Biomedical Imaging Laboratory (NIBIB)
$833,717David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2012 · EB